Viemed Healthcare, Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Casey Hoyt
- Full Time Employees
- 1,222
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 625 East Kaliste Saloom Road Lafayette LA United States of America 70508
- IPO Date
- Aug 9, 2019
- CIK
- 0001729149
- Website
- viemed.com
- Similar Companies
- Business
- Viemed Healthcare, Inc. operates as a leading national provider of in-home, technology-enabled post-acute respiratory care services in the United States. The company specializes in home medical equipment rental and respiratory disease management, delivering core products and services that include non-invasive ventilation (NIV) and invasive ventilation devices, BiPAP and CPAP devices for sleep apnea, oxygen concentrators and oxygen therapy, airway clearance and secretion management equipment such as percussion vests, and comprehensive sleep apnea diagnostic and therapy solutions. Viemed’s service model extends beyond equipment supply to include clinical respiratory disease management, personalized patient care with licensed respiratory therapists, remote patient monitoring using proprietary connected health technology, and disease management programs aimed at reducing hospital readmissions and improving patient outcomes. Founded in 2018 and headquartered in Lafayette, Louisiana, the company targets patients with chronic respiratory failure, chronic obstructive pulmonary disease (COPD), neuromuscular diseases, and obstructive sleep apnea, serving a broad geographic footprint across the U.S. through a combination of organic growth and strategic acquisitions. In recent developments, Viemed Healthcare completed a $26 million acquisition of Lehan's Medical Equipment in July 2025, expanding its care continuum into maternal health markets, reducing late-stage intervention dependency, and diversifying its revenue streams with recurring supply models. The company also announced and completed a significant share repurchase program authorized in mid-2024, underscoring confidence in its long-term growth prospects and financial strength. Operationally, Viemed reported record patient growth in 2024 and early 2025, with ventilator and PAP therapy patient counts increasing significantly, supported by ongoing ramp-up of its sales force and sales penetration strategies. The company raised its 2025 guidance with revenue expected between $271 million and $277 million and adjusted EBITDA projected between $59 million and $62 million. Viemed's strategic focus includes expanding payer diversification, leveraging regulatory developments favoring non-invasive ventilation, and addressing underserved markets with its high-touch, technology-enabled care model. The company benefits from strong national payer relationships, a growing patient base, and a scalable operational platform designed to enhance clinical outcomes and cost-effectiveness in home respiratory care. Viemed operates primarily in the healthcare and home medical equipment industry segments, focusing on technology-enabled post-acute respiratory care and disease management. It serves a diverse customer base including Medicare, Medicaid, private insurance payers, hospitals, health systems, and individual patients requiring chronic respiratory support. The company’s strategic growth initiatives emphasize market expansion through geography and service diversification, capitalizing on its technological capabilities and clinical expertise. Headquartered in Lafayette, Louisiana, Viemed continues to enhance its presence nationwide, supported by a national team of licensed respiratory therapists and clinical professionals providing in-home care and ongoing patient management. Overall, Viemed Healthcare, Inc. represents a specialized and growing entity in the home healthcare space, distinguished by its integration of advanced respiratory therapy technologies with comprehensive clinical support services aimed at improving patient quality of life and reducing healthcare system costs. Its recent financial performance, strategic acquisition, and operational improvements position it for sustained growth in a fragmented and high-demand market of in-home respiratory care solutions.
Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26
Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) Q1 Earnings Miss Estimates
Viemed Healthcare Announces First Quarter 2026 Financial Results
Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details
Michael Moore Sells 31,570 Shares of Viemed Healthcare (NASDAQ:VMD) Stock
Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 4Q 2025
Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript
Viemed Healthcare Announces 2026 Share Repurchase Program
Viemed Healthcare Announces Record 2025 Financial Results
Viemed Healthcare Announces Year End 2025 Earnings Conference Call Details
Viemed Healthcare: Remaining Bullish On Keen Valuation And Buoyant Cash Flow
Stonegate Capital Partners Initiates Coverage on Viemed Healthcare, Inc. (VMD)
Viemed Healthcare, Inc. (VMD) Q3 2025 Earnings Call Transcript
Viemed Healthcare Announces Third Quarter 2025 Financial Results
Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare Announces Completion of Share Repurchase Program
Viemed Healthcare, Inc. (VMD) Q2 2025 Earnings Call Transcript